Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-016053
Filing Date
2017-03-22
Accepted
2017-03-22 16:15:30
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE CAPITAL ASSOCIATES, L.P.LONGITUDE VENTURE PARTNERS, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A v462350_sc13da.htm SC 13D/A 106435
  Complete submission text file 0001144204-17-016053.txt   108046
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Subject) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80200 | Film No.: 17706833
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners, LLC (Filed by) CIK: 0001430720 (see all company filings)

EIN.: 261165932
Type: SC 13D/A